FDA Clearance Tracker · K253801
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
Last checked: Nov 20, 2026Latest source record: Apr 7, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Apr 7, 2026
Substantially Equivalent
Time to decision
130 days
Received Nov 28, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K253801
- Device name
- ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
- Applicant
- Anumana, Inc.
- Applicant location
- Cambridge, MA
- Received
- Nov 28, 2025
- Decided
- Apr 7, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2380
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SHP (Cardiac Amyloidosis Machine Learning-Based Notification Software).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K253801
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Anumana, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- WatchMate Software510(k)
K260300 · Decided Jun 15, 2026 · 136 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
- ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)Breakthrough510(k)
K252360 · Decided Mar 28, 2026 · 242 days after receipt
Device type: Pulmonary Hypertension Machine Learning-Based Notification Software (SAT) · Cardiology
K250652 · Decided Jul 28, 2025 · 146 days after receipt
Device type: Reduced Ejection Fraction Machine Learning-Based Notification Software (QYE) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.